Clinical Trial Update: Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

View source ↗

Summary

This update reports on a completed trial comparing piperacillin-tazobactam alone versus with a glycopeptide in neutropenic patients with hematologic malignancie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancy
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome
• Stem Cell Transplantation

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)
• Vancomycin (vancomycin)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hematological Malignancy, Leukemia | Status: COMPLETED